Komori
Immuno-Biological Laboratories (4570) · InitiativeRestated

Establishment of an Enterprise-Wide, Group-Wide Risk Management Framework

First written in FY2016. 2 of 4 entries say "Restated". Latest entry: FY2025.

4entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017RestatedFY2019 – FY20252016: 120162017: 120172018: 020182019: 120192020: 020202021: 020212022: 020222023: 020232024: 020242025: 12025
Same theme, other companies
Group-wide ERM and risk management frameworkA theme 260 companies write about · 4 as a headwind · 200 as a tailwind

79 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 262 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「The Company has appointed a chief risk management officer and established a cross-functional risk management framework covering the Company and its group companies.」

    The Company continues to operate a risk management framework covering the Company and its group companies under the chief risk management officer, along with a system for reporting the results of internal audits.
  2. FY2019RestatedAnnual report

    「The Company will appoint a chief risk management officer and establish a cross-functional risk management framework covering the Company and its group companies.」

    The Company continues to operate a risk management framework covering the Company and its group companies under the chief risk management officer, as well as a system for reporting the results of internal audits.
  3. FY2017AdvancedAnnual report

    「The Company will appoint a chief risk management officer and establish a cross-functional risk management framework covering the Company and its group companies.」

    The Company has specified the chief risk management officer, group-wide management, and a system for reporting the results of internal audits as components of its internal control system.
  4. FY2016First statedAnnual report

    「Accordingly, establishing an integrated, enterprise-wide risk management framework has become a key management issue, and the Company intends to progressively develop the organisation and rules needed to implement it.」

    The Company plans to appoint a chief risk management officer, establish a group-wide framework, and develop the relevant rules.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Immuno-Biological Laboratories yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Establishment of an Enterprise-Wide, Group-Wide Risk Management Framework | Immuno-Biological Laboratories Co.,Ltd. (4570) | Komori